• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94151ED
Device Problems Improper or Incorrect Procedure or Method (2017); No Apparent Adverse Event (3189)
Patient Problems Obstruction/Occlusion (2422); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/15/2023
Event Type  Injury  
Manufacturer Narrative
Clarification to section c.Suspect product: lot number 963/2.Continued h.6.Type of investigation code: b15, b17, b20.Continued h.6.Investigation conclusions code: d1102.Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reported that patient was injected in chin with 0.4ml juvéderm® voluma® with lidocaine.At the second injection site, the injection was stopped due to bruise/discoloration.10 minutes later, patient was treated with hyalase®.Injector noted the occlusion is unresolved; patient has had 8 vials of 1500iu hyalase®.It is unknown if symptom resolved.
 
Manufacturer Narrative
Previous medwatch submission noted the event as a serious injury.Abbvie medical safety determined that the event of bruising is not considered a serious injury.
 
Event Description
Per medical review, the reported symptoms are not the clinical presentation for vascular occlusion and use error.The reported event of bruise/discoloration is not a serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA WITH LIDOCAINE 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key17118577
MDR Text Key317121401
Report Number3005113652-2023-00470
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Nurse Practitioner
Type of Report Initial,Followup
Report Date 06/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number94151ED
Device Lot Number1000550127
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/18/2023
Initial Date FDA Received06/13/2023
Supplement Dates Manufacturer Received06/20/2023
Supplement Dates FDA Received06/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/23/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age61 YR
Patient SexFemale
-
-